These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

173 related items for PubMed ID: 25342386

  • 21. [Contributions of nuclear medicine to the diagnosis and follow-up of gastroenteropancreatic neuroendocrine tumors].
    Casanovas MM.
    Endocrinol Nutr; 2009 Sep; 56 Suppl 3():14-9. PubMed ID: 20542215
    [Abstract] [Full Text] [Related]

  • 22. Repeated peptide receptor radiotherapy in multiple recurrences of a metastasized neuroendocrine tumor.
    Brogsitter C, Zöphel K, Folprecht G, Eisenhofer G, Kotzerke J.
    Nuklearmedizin; 2017 Jun 12; 56(3):N19-N21. PubMed ID: 28358166
    [No Abstract] [Full Text] [Related]

  • 23. 18F-fluorodihydroxyphenylalanine in the diagnosis of neuroendocrine tumors.
    Minn H, Kemppainen J, Kauhanen S, Forsback S, Seppänen M.
    PET Clin; 2014 Jan 12; 9(1):27-36. PubMed ID: 25029931
    [Abstract] [Full Text] [Related]

  • 24. Lutetium lu 177 dotatate (Lutathera) for gastroenteropancreatic neuroendocrine tumors.
    Med Lett Drugs Ther; 2018 Sep 10; 60(1555):e152-e153. PubMed ID: 30383735
    [No Abstract] [Full Text] [Related]

  • 25. An Incidental Uptake of 18F-Choline at PET/CT in Gastric Neuroendocrine Tumor.
    Evangelista L, Cassarino G, Capobianco D, Povolato M, Battista S, Rensi M.
    Clin Nucl Med; 2021 Apr 01; 46(4):e238-e239. PubMed ID: 33031248
    [Abstract] [Full Text] [Related]

  • 26. Other PET tracers for neuroendocrine tumors.
    Koopmans KP, Glaudemans AW.
    PET Clin; 2014 Jan 01; 9(1):57-62. PubMed ID: 25029934
    [Abstract] [Full Text] [Related]

  • 27. Diffuse Bone Metastases in Pancreatic Neuroendocrine Tumor Shown on Octreoscan.
    Adkins J, Lu Y.
    Clin Nucl Med; 2019 Mar 01; 44(3):257-258. PubMed ID: 30624276
    [Abstract] [Full Text] [Related]

  • 28. Gastroenteropancreatic neuroendocrine tumors: standardizing therapy monitoring with 68Ga-DOTATOC PET/CT using the example of somatostatin receptor radionuclide therapy.
    Luboldt W, Hartmann H, Wiedemann B, Zöphel K, Luboldt HJ.
    Mol Imaging; 2010 Dec 01; 9(6):351-8. PubMed ID: 21084031
    [Abstract] [Full Text] [Related]

  • 29. Does the pretherapeutic tumor SUV in 68Ga DOTATOC PET predict the absorbed dose of 177Lu octreotate?
    Ezziddin S, Lohmar J, Yong-Hing CJ, Sabet A, Ahmadzadehfar H, Kukuk G, Biersack HJ, Guhlke S, Reichmann K.
    Clin Nucl Med; 2012 Jun 01; 37(6):e141-7. PubMed ID: 22614212
    [Abstract] [Full Text] [Related]

  • 30. Early evaluation of sunitinib for the treatment of advanced gastroenteropancreatic neuroendocrine neoplasms via CT imaging: RECIST 1.1 or Choi Criteria?
    Luo Y, Chen J, Huang K, Lin Y, Chen M, Xu L, Li ZP, Feng ST.
    BMC Cancer; 2017 Feb 23; 17(1):154. PubMed ID: 28231773
    [Abstract] [Full Text] [Related]

  • 31. Combined 18F-FDG PET/CT and 68Ga DOTATATE PET/CT "Superscan" in Metastatic Pancreatic Neuroendocrine Tumor.
    Chan M, Schembri GP.
    Clin Nucl Med; 2017 Feb 23; 42(2):108-109. PubMed ID: 27997429
    [Abstract] [Full Text] [Related]

  • 32. [Positron emission tomography with fluorodeoxyglucose in gastro-entero-pancreatic tumors: diagnostic role and prognostic implications].
    Pasquali C, Sperti C, Lunardi C, Scappin S, Chierichetti F, Liessi G, Pedrazzoli S.
    Suppl Tumori; 2005 Feb 23; 4(3):S68-71. PubMed ID: 16437910
    [Abstract] [Full Text] [Related]

  • 33. Clinical Usefulness of Somatostatin Receptor Scintigraphy in Japanese Patients with Gastroenteropancreatic Neuroendocrine Tumors.
    Hasegawa S, Kobayashi N, Tokuhisa M, Goto A, Takano S, Takada Y, Kaneta T, Mori R, Matsuyama R, Endo I, Yamanaka S, Nakajima A, Inoue T, Ichikawa Y.
    Digestion; 2017 Feb 23; 96(1):13-20. PubMed ID: 28609761
    [Abstract] [Full Text] [Related]

  • 34. Delayed imaging with oral contrast improves [68Ga]Ga-DOTANOC PET/CT detection of primary duodenal neuroendocrine tumor (NET).
    Mei R, Allegri V, Calabrò D, Fanti S, Ambrosini V.
    Eur J Nucl Med Mol Imaging; 2021 May 23; 48(5):1684-1685. PubMed ID: 33423095
    [No Abstract] [Full Text] [Related]

  • 35. Impact of F18-fluorodeoxyglycose positron emission tomography/computed tomography on the management of resectable pancreatic tumours.
    Yao J, Gan G, Farlow D, Laurence JM, Hollands M, Richardson A, Pleass HC, Lam VW.
    ANZ J Surg; 2012 Mar 23; 82(3):140-4. PubMed ID: 22510123
    [Abstract] [Full Text] [Related]

  • 36. Combined Volumetric and Density Analyses of Contrast-Enhanced CT Imaging to Assess Drug Therapy Response in Gastroenteropancreatic Neuroendocrine Diffuse Liver Metastasis.
    Wang Y, Huang K, Chen J, Luo Y, Zhang Y, Jia Y, Xu L, Chen M, Huang B, Ni D, Li ZP, Feng ST.
    Contrast Media Mol Imaging; 2018 Mar 23; 2018():6037273. PubMed ID: 30510495
    [Abstract] [Full Text] [Related]

  • 37. The Latest Advances in Peptide Receptor Radionuclide Therapy for Gastroenteropancreatic Neuroendocrine Tumors.
    Hindié E, Baudin E, Hicks RJ, Taïeb D.
    J Nucl Med; 2023 Apr 23; 64(4):522-524. PubMed ID: 36604184
    [No Abstract] [Full Text] [Related]

  • 38. Gallium-68-DOTA-NOC PET/CT of patients with gastroenteropancreatic neuroendocrine tumors: a prospective single-center study.
    Naswa N, Sharma P, Kumar A, Nazar AH, Kumar R, Chumber S, Bal C.
    AJR Am J Roentgenol; 2011 Nov 23; 197(5):1221-8. PubMed ID: 22021518
    [Abstract] [Full Text] [Related]

  • 39. Staging and follow-up of gastrointestinal tumors with PET/CT.
    Rosenbaum SJ, Stergar H, Antoch G, Veit P, Bockisch A, Kühl H.
    Abdom Imaging; 2006 Nov 23; 31(1):25-35. PubMed ID: 16333707
    [Abstract] [Full Text] [Related]

  • 40. When should F-18 FDG PET/CT be used instead of 68Ga-DOTA-peptides to investigate metastatic neuroendocrine tumors?
    Fuccio C, Musto A, Cambioli S, Castellucci P, Pantaleo MA, Nanni C, Montini GC, Campana D, Tomassetti P, Bellan E, Massaro A, Grassetto G, Rubello D, Fanti S.
    Clin Nucl Med; 2011 Dec 23; 36(12):1109-11. PubMed ID: 22064082
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.